“The North’s expertise in delivering innovations through joint working between hospitals, academics and industry is demonstrated by the fact it has been awarded three of the seven NHS testbeds.
These are important collaborations which have the potential to make a big difference to patientcare across the country.
There is a patient population of 15 million in the North and our strengths in eHealth, learning health systems and collaborative working mean that we are well equipped to deliver pioneering treatments in the right way to make a difference in people’s lives.
This kind of partnership which implements new technology in a way in which is evaluated properly by healthcare experts will ultimately lead to improving the health of patients across the North and beyond.”
For any more information contact Hannah Davies, Communications Manager at the NHSA hannah.davies@theNHSA.co.uk, 07342882383
The Northern Health Science Alliance Ltd (NHSA) is a partnership established by the leading Universities and NHS Hospital Trusts in the North of England to improve the health and wealth of the region by creating an internationally recognised life science and healthcare system.
The NHSA links eight universities and eight NHS Teaching Trusts with the newly formed Academic Health Science Networks (AHSNs). Together the Alliance and the four Northern AHSNs cover a patient population of over 15 million people.
The NHSA acts as a single portal bringing together research, health science innovation and commercialisation to provide benefits for researchers, universities and patients.
More information is available on www.thenhsa.co.uk
Perfect Patient Pathway Test Bed –aims to create the ‘perfect patient pathway’ to bring substantial benefits for patients in the Sheffield City Region suffering from long term conditions, such as diabetes, mental health problems, respiratory disease, hypertension and other chronic conditions. The Test Bed will keep patients with long term conditions well, independent and avoiding crisis points which often result in hospital admission, intensive rehabilitation and a high level of social care support. Working in partnership with GE Finnamore, IBM and 13 smaller innovators, the local health and care system will set up an integrated intelligence centre to help get people the help they need, when they need it most.
Long Term Conditions Early Intervention Programme –will see the NHS in Heywood, Middleton and Rochdale working with Verily (formerly Google Life Sciences), MSD, Health E Research and the Greater Manchester Academic Health Science Network to help healthcare professionals better identify and support patients at risk of long term conditions using the most advanced new predictive techniques. This will involve analysing trends and patterns related to conditions like heart failure and some lung diseases such as Chronic Obstructive Pulmonary Disease to identify patients who would most benefit from tele-health, tele-care and tele-medicine technology. These patients will benefit from a more personalised service, in particular being proactively offered additional physician support and access to technology.
Lancashire and Cumbria Innovation Alliance (LCIA) Test Bed –will see the NHS, including two New Care Model Vanguard sites, partner with Philips and a number of SMEs and social enterprises to support the frail elderly and people with long term conditions to remain well outside of hospital and avoid unnecessary admissions. They will test new approaches to identifying patients that can benefit from additional support and help them to self-care at home through improved education and telehealth technologies.
Related News Articles
Partnership harnesses UK health and life sciences expertise
Impact report highlights successes of Research England-funded NHSA and MedCity partnership
Two Digital Health Hubs awarded to the North of England
Two Engineering and Physical Sciences Research Council (EPSRC) Health Hubs have been created in the North
Join us for a Meet and Match Cell and Gene Therapy event with our UK and German partners
Join us for a meet and match cell and gene therapy event with UK and German Partners